Two Synthetic THC Medicines, One Evidence Review, Opposite Results for Pain
An updated federal evidence review of 25 randomized trials found that nabilone for chronic pain reduced pain severity by a pooled 1.59 points while dronabinol, the other oral synthetic cannabinoid, reduced it by 0.23. Across product categories,…
How the Body Switches Off Its Own Cannabinoids, and What Happened When a Drug Company Tried to Stop It
Endocannabinoid degradation runs through two enzymes: FAAH, which converts anandamide to arachidonic acid and ethanolamine, and MAGL, which converts 2-AG to arachidonic acid and glycerol and handles about 85 percent of brain 2-AG hydrolysis. Blocking…
CBG, CBN, CBC, and THCV: Which Cannabinoid Claims Come From Human Studies, and Which Do Not
Minor cannabinoids reach store shelves with confident functional claims years before anyone gives them to a human being in a controlled trial. CBG now has two small human studies that reached different conclusions, CBN has two randomized sleep trials…
Can Oral Mucosal Delivery Unlock Cannabinoid Medicine’s Potential?
Oral mucosal cannabinoid absorption offers a promising alternative to traditional oral ingestion by bypassing hepatic metabolism. This method enhances bioavailability and may improve therapeutic consistency. Understanding these delivery systems is…
Cannabinoid Pain Relief: Evidence-Based Clinical Guide
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve impulse transmission, with preclinical evidence showing reduced pain-related neuronal activity. Current research demonstrates that cannabinoid…
Understanding Cannabidiol Supplement Use and WADA Drug Testing Results
Cannabidiol supplements and WADA-prohibited cannabinoids pose doping risks for athletes. Broad-spectrum CBD products can lead to positive anti-doping tests due to trace cannabinoids. Athletes should prefer CBD isolate to avoid unintended WADA violations.
Exploring Minor Cannabinoids and Terpenes in Cannabis Therapy
Minor cannabinoids and terpenes play a crucial role in the entourage effect by physically binding to cannabinoid receptors. This interaction may enhance therapeutic outcomes beyond isolated compounds. Understanding minor cannabinoids and terpenes helps…
Cannabinoids and Pain: Pharmacology and Clinical Evidence
Cannabinoid pharmacology pain management is critical for understanding medical cannabis use in chronic pain. This review synthesizes mechanisms, dosing, and clinical evidence. Clinicians benefit from educational resources bridging patient demand and…
Cannabinoid Pain Relief: Sodium Channel Modulation Research
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve transmission, based on laboratory evidence from multiple studies. This mechanism may explain part of cannabinoids' pain-relieving effects, though…
Cannabis Use Patterns and Acute Pain Perception During Brief Abstinence
This clinical study investigates acute pain cannabinoid withdrawal during brief cannabis abstinence. It reveals sex-dependent differences linked to circulating cannabinoid levels. Understanding these patterns aids personalized pain management strategies.
